Validation of a language test for Swiss German children
Validation of a Swiss German Language Test for Children
Insel Gruppe AG, University Hospital Bern · NCT06567613
This study is testing a new language test for Swiss German-speaking kids aged 4 to 6 to see how well they can pronounce simple words and set standards for their language development.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 180 (estimated) |
| Ages | 4 Years to 6 Years |
| Sex | All |
| Sponsor | Insel Gruppe AG, University Hospital Bern (other) |
| Locations | 4 sites (Basel and 3 other locations) |
| Trial ID | NCT06567613 on ClinicalTrials.gov |
What this trial studies
This observational study aims to validate a language test specifically designed for Swiss German-speaking children aged 4-6 years. It will assess the speech intelligibility of monosyllables and disyllables in children with normal hearing. The study will record standard values to establish benchmarks for language development in this demographic. By focusing on children with a hearing threshold better than 20dB HL, the study seeks to ensure accurate assessment of language skills without the confounding factor of hearing loss.
Who should consider this trial
Good fit: Ideal candidates for this study are native Swiss German-speaking children aged 4-6 years with normal hearing.
Not a fit: Patients with hearing loss or cognitive impairment will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide standardized language assessment tools for early identification of language development issues in Swiss German-speaking children.
How similar studies have performed: While this specific approach is focused on Swiss German language assessment, similar studies validating language tests in other languages have shown success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Native Swiss German speakers * Hearing threshold better than 20dB HL at 0.5, 1, 2 and 4kHz * Written informed consent by the parents Exclusion Criteria: * Hearing loss * Cognitive impairment
Where this trial is running
Basel and 3 other locations
- Universitätsspital Basel — Basel, Switzerland (RECRUITING)
- Inselspital Bern — Bern, Switzerland (RECRUITING)
- Kantonsspital Luzern — Luzern, Switzerland (RECRUITING)
- Universitätsspital Zürich — Zürich, Switzerland (RECRUITING)
Study contacts
- Principal investigator: Christoph Schmid — Inselspital Bern, Berne University Hospital
- Study coordinator: Christoph Schmid
- Email: christoph.schmid@insel.ch
- Phone: 031 632 33 83
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Hearing Loss